Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Origin: Made in South Korea
Methods Sixty-eight subjects (1875 years
Specifically, the ELIXA (lixisenatide) trial studied patients with T2DM who had recent acute coronary syndrome and found that the addition of lixisenatide to conventional therapy did not result in a significant difference in cardiovascular endpoints relative to placebo (Table 1) [56]
& Parpura, V
US$ 27.97
)
US$ 20.64
US$ 24.81
US$ 29.84
US$ 22.34
US$ 26.45
